This article is more than 5 years old. Information may no longer be current.

Carl Zeiss Meditec acquires Aaren Scientific

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Carl Zeiss Meditec AG has acquired 100% of the shares in Aaren Scientific, according to a press release.

Aaren Scientific will be integrated into Carl Zeiss Meditec’s surgical ophthalmology strategic business unit and will complement the company’s IOL development and manufacturing sites in Berlin and La Rochelle, France. The surgical ophthalmology strategic business unit has reported above market growth rates for the last 3 to 4 years due to strong demand for innovative IOLs, the release said.

Aaren Scientific, based in Ontario, Calif., was the first U.S. IOL manufacturer to receive a CE registration. The company has 235 employees and, in 2012, had total revenues of approximately $20 million, primarily generated outside of the U.S., according to the release.

The management team of Aaren Scientific, including CEO and co-founder Rick Aguilera, will stay with the company after the transaction is completed.